Christian W. Hamm, MD, PhD, FESC

Peptide-Treated Stent Graft for the Treatment of Saphenous Vein Graft Lesions: First Clinical Results

08/01/2008

Thomas Münzel , MD;

Ralf Kösterf , MD;

Andreas M. Zeiher , MD;

Christian Maikowski , MD;

Christian W. Hamm , MD, PhD, FESC;

Tassilo Bonzel , MD;

Matthias Rau , MD;

Volker Schäachinger , MD;

Percutaneous interventions of degenerated saphenous vein grafts (SVGs) are associated with high rates of distal embolic events and in-stent restenosis.1 Recent experience with covered stents suggests that these types of devices may be a...

Percutaneous interventions of...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Net Clinical Benefit of Prehospital Glycoprotein IIb/IIIa Inhibitors in Patients with ST-Elevation Myocardial Infarction and High Risk of Bleeding: Effect of Tirofiban in Patients at High Risk of Bleeding Using CRUSADE Bleeding Score

02/29/2012

Christian W. Hamm , MD, PhD, FESC;

Jurrien M. ten Berg , MD, PhD;

Arnoud W.J. van't Hof , MD, PhD;

Renicus S. Hermanides , MD;

A.T. Marcel Gosselink , MD, PhD;

Gert van Houwelingen , MD;

Jan-Henk E. Dambrink , MD, PhD;

Pieter R. Stella , MD, PhD;

Jan Paul Ottervanger , MD, PhD;

Abstract: Aims. The aim of this subanalysis was to assess the net clinical effect of prehospital administration of tirofiban in ST-elevation myocardial infarction (STEMI) patients with high risk of bleeding. Methods. This is a retrospective...

Abstract: Aims. The aim of this...

02/29/2012

Journal of Invasive Cardiology

Original Contribution

Comparison of Twelve-Month Outcomes After Percutanous Coronary Intervention With Everolimus-Eluting Versus Zotarolimus-Eluting or Sirolimus-Eluting Stents From the PROENCY (PROmus ENdeavor CYpher) Registry

10/01/2012

Jan G.P. Tijssen , PhD;

Paul Underwood , MD;

Christian W. Hamm , MD, PhD, FESC;

Peter Damman , MD;

Mohamed Abdel-Wahab , MD;

Gert Richardt , MD, PhD;

Bernard Chevalier , MD;

Paul Barragan , MD;

Abstract: Objectives. We compared safety and efficacy outcomes of 3 limus-based drug-eluting stents in the ‘all-comers’ PROENCY (PROmus/ENdeavor /CYpher) registry. Background. Limited data are available on head-to-head comparisons of the...

Abstract: Objectives. We...

10/01/2012

Journal of Invasive Cardiology

Impact of Rapid Ventricular Pacing During Transcatheter Implantation of Self-Expanding Aortic Valve Prostheses in Patients at Highest Risk

12/01/2020

Christoph Liebetrau , MD, PhD;

Matthias Renker , MD;

Helge Möllmann , MD, PhD;

Christian W. Hamm , MD, PhD, FESC;

Ulrich Fischer-Rasokat , MD, PhD;

Won-Keun Kim , MD;

Patients with low-flow, low-gradient (LFLG) aortic stenosis (AS) have the highest risk among all AS patients. We investigated the effects of rapid ventricular pacing in patients with LFLG-AS.

Patients with low-flow,...

12/01/2020

Journal of Invasive Cardiology

Original Research

Efficacy and Safety of Postdilation for a Self-Expanding Transcatheter Heart Valve

05/19/2022

Christian W. Hamm , MD, PhD, FESC;

Won-Keun Kim , MD;

Matthias Renker , MD;

Holger Nef , MD;

Helge Möllmann , MD, PhD;

Thomas Walther , MD, PhD;

Yeong-Hoon Choi , MD, PhD;

Data are lacking regarding the outcomes of balloon postdilation (BPD) for the Acurate neo and neo2 devices. The aim of this study was to assess the impact of BPD in a large, single-center cohort of patients treated with the Acurate platform.

Data are lacking regarding the...

05/19/2022

Journal of Invasive Cardiology

Original Contribution

A Novel Model to Predict 1-Year Mortality in Elective Transfemoral Aortic Valve Replacement: The TAVR-Risk Score

10/13/2022

Georg Wolff , MD;

Raphael Romano Bruno , MD;

Tobias Zeus , MD;

Artur Lichtenberg ;

Malte Kelm , MD;

Friedhelm Beyersdorf ;

Christian Jung , MD, PhD;

Christian W. Hamm , MD, PhD, FESC;

Jan Gummert , MD, PhD;

Andreas M. Zeiher , MD;

Magnus Settergren , MD;

Amin Polzin , MD;

Bernhard Wernly , MD, PhD;

Christian Frerker , MD;

Raffi Bekeredjian , MD;

Timm Bauer , MD;

Andreas Beckmann , MD;

Sabine Bleiziffer , MD;

Stephan M. Ensminger , MD, PhD;

Helge Möllmann , MD, PhD;

Christopher U. Meduri , MD, MPH;

Thomas Walther , MD, PhD;

Kari Feldt , MD;

We aimed to develop and validate an effective prediction model for 1-year mortality risk in elective transfemoral transcatheter aortic valve replacement (TAVR), ie, the TAVR-Risk (TARI) model.

We aimed to develop and validate...

10/13/2022

Journal of Invasive Cardiology